{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:50:49Z","timestamp":1792785049777,"version":"4.5.0"},"reference-count":70,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T00:00:00Z","timestamp":1782345600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T00:00:00Z","timestamp":1790035200000},"content-version":"vor","delay-in-days":89,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"https:\/\/ror.org\/00x0ma614","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"https:\/\/ror.org\/00x0ma614","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"https:\/\/ror.org\/00x0ma614","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"https:\/\/ror.org\/00x0ma614","id-type":"ROR","asserted-by":"crossref"}]},{"name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"https:\/\/ror.org\/00x0ma614","id-type":"ROR","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["442472\/2024-2"],"award-info":[{"award-number":["442472\/2024-2"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004901","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa do Estado de Minas Gerais","doi-asserted-by":"publisher","award":["APQ-01297-23"],"award-info":[{"award-number":["APQ-01297-23"]}],"id":[{"id":"10.13039\/501100004901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-59872-2","type":"journal-article","created":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T20:05:12Z","timestamp":1782417912000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Optimizing DNA and mRNA vaccine against Human metapneumovirus structural proteins based on rationally designed multi-epitope construct"],"prefix":"10.1038","volume":"16","author":[{"given":"Leonardo Pereira","family":"de Ara\u00fajo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Leone","family":"da Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9 Luiz Caliari","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guilherme Landim","family":"de Rezende","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evandro Neves","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patr\u00edcia Paiva","family":"Corsetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo Augusto","family":"de Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,6,25]]},"reference":[{"key":"59872_CR1","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1111\/imm.13844","volume":"173","author":"T Troncoso-Bravo","year":"2024","unstructured":"Troncoso-Bravo, T. et al. Advancement in the development of mRNA-based vaccines for respiratory viruses. Immunology 173, 481\u2013496. https:\/\/doi.org\/10.1111\/imm.13844 (2024).","journal-title":"Immunology"},{"key":"59872_CR2","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2025.1584876","author":"EN Konopka","year":"2025","unstructured":"Konopka, E. N., Edgerton, A. O. & Kutzler, M. A. Nucleic acid vaccines: innovations, efficacy, and applications in at-risk populations. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2025.1584876 (2025).","journal-title":"Front. Immunol."},{"key":"59872_CR3","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.633776","author":"F Qin","year":"2021","unstructured":"Qin, F. et al. A guide to nucleic acid vaccines in the prevention and treatment of infectious diseases and cancers: From basic principles to current applications. Front. Cell Dev. Biol. https:\/\/doi.org\/10.3389\/fcell.2021.633776 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"59872_CR4","doi-asserted-by":"publisher","first-page":"5271","DOI":"10.2147\/idr.s341694","volume":"14","author":"N Nitika","year":"2021","unstructured":"Nitika, N., Wei, J. & Hui, A.-M. The development of mRNA vaccines for infectious diseases: recent updates. Infect. Drug Resist. 14, 5271\u20135285. https:\/\/doi.org\/10.2147\/idr.s341694 (2021).","journal-title":"Infect. Drug Resist."},{"key":"59872_CR5","doi-asserted-by":"publisher","DOI":"10.7759\/cureus.78354","author":"B Mishra","year":"2025","unstructured":"Mishra, B., Mohapatra, D., Tripathy, M., Mamidi, P. & Mohapatra, P. R. A re-emerging respiratory virus: Human metapneumovirus (HMPV). Cureus https:\/\/doi.org\/10.7759\/cureus.78354 (2025).","journal-title":"Cureus"},{"key":"59872_CR6","doi-asserted-by":"publisher","first-page":"e732","DOI":"10.1016\/s2666-5247(23)00134-9","volume":"4","author":"L Guo","year":"2023","unstructured":"Guo, L., Li, L., Liu, L., Zhang, T. & Sun, M. Neutralising antibodies against human metapneumovirus. Lancet Microbe 4, e732\u2013e744. https:\/\/doi.org\/10.1016\/s2666-5247(23)00134-9 (2023).","journal-title":"Lancet Microbe"},{"key":"59872_CR7","doi-asserted-by":"publisher","first-page":"505","DOI":"10.3390\/v10090505","volume":"10","author":"IK Uche","year":"2018","unstructured":"Uche, I. K. & Guerrero-Plata, A. Interferon-mediated response to human metapneumovirus infection. Viruses 10, 505. https:\/\/doi.org\/10.3390\/v10090505 (2018).","journal-title":"Viruses"},{"key":"59872_CR8","doi-asserted-by":"publisher","DOI":"10.1016\/j.nmni.2025.101563","volume":"63","author":"JA Al-Tawfiq","year":"2025","unstructured":"Al-Tawfiq, J. A. & Memish, Z. A. The surge of human metapneumovirus (HMPV) cases in China and global implications. New Microbes New Infect. 63, 101563. https:\/\/doi.org\/10.1016\/j.nmni.2025.101563 (2025).","journal-title":"New Microbes New Infect."},{"key":"59872_CR9","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-022-28931-3","author":"C-L Hsieh","year":"2022","unstructured":"Hsieh, C.-L. et al. Structure-based design of prefusion-stabilized human metapneumovirus fusion proteins. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-022-28931-3 (2022).","journal-title":"Nat. Commun."},{"key":"59872_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43434-5","author":"JD Whitehead","year":"2023","unstructured":"Whitehead, J. D. et al. Structure of the N-RNA\/P interface indicates mode of L\/P recruitment to the nucleocapsid of human metapneumovirus. Nat. Commun. https:\/\/doi.org\/10.1038\/s41467-023-43434-5 (2023).","journal-title":"Nat. Commun."},{"key":"59872_CR11","doi-asserted-by":"publisher","first-page":"107604","DOI":"10.1016\/j.rmed.2024.107604","volume":"227","author":"A Al-Hamoud","year":"2024","unstructured":"Al-Hamoud, A. et al. Determinants of radiological patterns and severity in immunocompromised adults with Metapneumovirus infection. Respir. Med. 227, 107604. https:\/\/doi.org\/10.1016\/j.rmed.2024.107604 (2024).","journal-title":"Respir. Med."},{"key":"59872_CR12","doi-asserted-by":"publisher","first-page":"579","DOI":"10.1002\/jmv.26401","volume":"93","author":"S Hashemi","year":"2020","unstructured":"Hashemi, S. et al. Report of death in children with SARS-CoV-2 and human metapneumovirus (hMPV) coinfection: Is hMPV the trigger?. J. Med. Virol. 93, 579\u2013581. https:\/\/doi.org\/10.1002\/jmv.26401 (2020).","journal-title":"J. Med. Virol."},{"key":"59872_CR13","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1016\/j.rmcr.2013.12.007","volume":"12","author":"M Seki","year":"2014","unstructured":"Seki, M. et al. Severe respiratory failure due to co-infection with human metapneumovirus and Streptococcus pneumoniae. Respir. Med. Case Rep. 12, 13\u201315. https:\/\/doi.org\/10.1016\/j.rmcr.2013.12.007 (2014).","journal-title":"Respir. Med. Case Rep."},{"key":"59872_CR14","doi-asserted-by":"publisher","DOI":"10.1038\/s41541-024-00899-9","author":"D Ogonczyk-Makowska","year":"2024","unstructured":"Ogonczyk-Makowska, D. et al. Mucosal bivalent live attenuated vaccine protects against human metapneumovirus and respiratory syncytial virus in mice. Npj Vaccines https:\/\/doi.org\/10.1038\/s41541-024-00899-9 (2024).","journal-title":"Npj Vaccines"},{"key":"59872_CR15","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1093\/jpids\/pix006","volume":"7","author":"RA Karron","year":"2017","unstructured":"Karron, R. A., Mateo, J. S., Wanionek, K., Collins, P. L. & Buchholz, U. J. Evaluation of a live attenuated human metapneumovirus vaccine in adults and children. J. Pediatr. Infect. Dis. Soc. 7, 86\u201389. https:\/\/doi.org\/10.1093\/jpids\/pix006 (2017).","journal-title":"J. Pediatr. Infect. Dis. Soc."},{"key":"59872_CR16","doi-asserted-by":"publisher","DOI":"10.1093\/ofid\/ofac206","author":"A August","year":"2022","unstructured":"August, A. et al. Safety and immunogenicity of an mRNA-based human metapneumovirus and parainfluenza virus type 3 combined vaccine in healthy adults. Open Forum Infect. Dis. https:\/\/doi.org\/10.1093\/ofid\/ofac206 (2022).","journal-title":"Open Forum Infect. Dis."},{"key":"59872_CR17","doi-asserted-by":"publisher","first-page":"8518","DOI":"10.1016\/j.vaccine.2007.10.022","volume":"25","author":"RL De Swart","year":"2007","unstructured":"De Swart, R. L. et al. Immunization of macaques with formalin-inactivated human metapneumovirus induces hypersensitivity to hMPV infection. Vaccine 25, 8518\u20138528. https:\/\/doi.org\/10.1016\/j.vaccine.2007.10.022 (2007).","journal-title":"Vaccine"},{"key":"59872_CR18","doi-asserted-by":"publisher","first-page":"3391","DOI":"10.1099\/vir.0.83250-0","volume":"88","author":"M-\u00c8 Hamelin","year":"2007","unstructured":"Hamelin, M. -\u00c8., Couture, C., Sackett, M. K. & Boivin, G. Enhanced lung disease and Th2 response following human metapneumovirus infection in mice immunized with the inactivated virus. J. Gen. Virol. 88, 3391\u20133400. https:\/\/doi.org\/10.1099\/vir.0.83250-0 (2007).","journal-title":"J. Gen. Virol."},{"key":"59872_CR19","doi-asserted-by":"publisher","first-page":"e2","DOI":"10.1016\/s1473-3099(22)00291-2","volume":"23","author":"NI Mazur","year":"2022","unstructured":"Mazur, N. I. et al. Respiratory syncytial virus prevention within reach: The vaccine and monoclonal antibody landscape. Lancet. Infect. Dis 23, e2\u2013e21. https:\/\/doi.org\/10.1016\/s1473-3099(22)00291-2 (2022).","journal-title":"Lancet. Infect. Dis"},{"key":"59872_CR20","doi-asserted-by":"publisher","first-page":"100015","DOI":"10.1016\/j.immuno.2022.100015","volume":"7","author":"LP De Ara\u00fajo","year":"2022","unstructured":"De Ara\u00fajo, L. P. et al. Epitope identification of SARS-CoV-2 structural proteins using in silico approaches to obtain a conserved rational immunogenic peptide. ImmunoInformatics 7, 100015. https:\/\/doi.org\/10.1016\/j.immuno.2022.100015 (2022).","journal-title":"ImmunoInformatics"},{"key":"59872_CR21","doi-asserted-by":"publisher","first-page":"S285","DOI":"10.1093\/infdis\/jiad443","volume":"229","author":"LP De Ara\u00fajo","year":"2023","unstructured":"De Ara\u00fajo, L. P., De Melo Santos, N. C., Corsetti, P. P. & De Almeida, L. A. Immunoinformatic approach for rational identification of immunogenic peptides against host entry and\/or exit MPOX proteins and potential multiepitope vaccine construction. J. Infect. Dis. 229, S285\u2013S292. https:\/\/doi.org\/10.1093\/infdis\/jiad443 (2023).","journal-title":"J. Infect. Dis."},{"key":"59872_CR22","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/s2666-5247(24)00095-8","volume":"5","author":"LP De Ara\u00fajo","year":"2024","unstructured":"De Ara\u00fajo, L. P., Silva, E. N., Corsetti, P. P. & De Almeida, L. A. Shared immunogenic epitopes between host entry and exit proteins from monkeypox and Alaskapox viruses. Lancet Microbe 5, 624\u2013625. https:\/\/doi.org\/10.1016\/s2666-5247(24)00095-8 (2024).","journal-title":"Lancet Microbe"},{"key":"59872_CR23","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-025-96755-4","author":"LP De Ara\u00fajo","year":"2025","unstructured":"De Ara\u00fajo, L. P., Silva, E. N., De Alencar, S. M., Corsetti, P. P. & De Almeida, L. A. Multivalent vaccine candidate from conserved immunogenic peptides in entry or exit proteins of Orthopoxvirus genus. Sci. Rep. https:\/\/doi.org\/10.1038\/s41598-025-96755-4 (2025).","journal-title":"Sci. Rep."},{"key":"59872_CR24","doi-asserted-by":"publisher","DOI":"10.1016\/j.actatropica.2025.107575","volume":"263","author":"LB Silva","year":"2025","unstructured":"Silva, L. B. et al. A computational approach for MHC-restricted multi-epitope vaccine design targeting Oropouche virus structural proteins. Acta Trop. 263, 107575. https:\/\/doi.org\/10.1016\/j.actatropica.2025.107575 (2025).","journal-title":"Acta Trop."},{"key":"59872_CR25","doi-asserted-by":"publisher","first-page":"W24","DOI":"10.1093\/nar\/gkx346","volume":"45","author":"MC Jespersen","year":"2017","unstructured":"Jespersen, M. C., Peters, B., Nielsen, M. & Marcatili, P. BepiPred-2.0: Improving sequence-based B-cell epitope prediction using conformational epitopes. Nucleic Acids Res. 45, W24\u2013W29. https:\/\/doi.org\/10.1093\/nar\/gkx346 (2017).","journal-title":"Nucleic Acids Res."},{"issue":"2018","key":"59872_CR26","doi-asserted-by":"publisher","first-page":"D339","DOI":"10.1093\/nar\/gky1006","volume":"47","author":"R Vita","year":"2018","unstructured":"Vita, R. et al. The Immune Epitope Database (IEDB): 2018 update. Nucleic Acids Res. 47(2018), D339\u2013D343. https:\/\/doi.org\/10.1093\/nar\/gky1006 (2018).","journal-title":"Nucleic Acids Res."},{"key":"59872_CR27","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/nbt1215","volume":"24","author":"M Moutaftsi","year":"2006","unstructured":"Moutaftsi, M. et al. A consensus epitope prediction approach identifies the breadth of murine TCD8+-cell responses to vaccinia virus. Nat. Biotechnol. 24, 817\u2013819. https:\/\/doi.org\/10.1038\/nbt1215 (2006).","journal-title":"Nat. Biotechnol."},{"key":"59872_CR28","doi-asserted-by":"publisher","first-page":"4928","DOI":"10.1128\/jvi.02632-06","volume":"81","author":"MF Kotturi","year":"2007","unstructured":"Kotturi, M. F. et al. The CD8+T-Cell response to lymphocytic choriomeningitis virus involves the L antigen: Uncovering new tricks for an old virus. J. Virol. 81, 4928\u20134940. https:\/\/doi.org\/10.1128\/jvi.02632-06 (2007).","journal-title":"J. Virol."},{"key":"59872_CR29","doi-asserted-by":"publisher","first-page":"325","DOI":"10.1007\/s00251-011-0513-0","volume":"63","author":"J Greenbaum","year":"2011","unstructured":"Greenbaum, J. et al. Functional classification of class II human leukocyte antigen (HLA) molecules reveals seven different supertypes and a surprising degree of repertoire sharing across supertypes. Immunogenetics 63, 325\u2013335. https:\/\/doi.org\/10.1007\/s00251-011-0513-0 (2011).","journal-title":"Immunogenetics"},{"key":"59872_CR30","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-8-4","author":"IA Doytchinova","year":"2007","unstructured":"Doytchinova, I. A. & Flower, D. R. VaxiJen: A server for prediction of protective antigens, tumour antigens and subunit vaccines. BMC Bioinform. https:\/\/doi.org\/10.1186\/1471-2105-8-4 (2007).","journal-title":"BMC Bioinform."},{"key":"59872_CR31","doi-asserted-by":"publisher","first-page":"W36","DOI":"10.1093\/nar\/gkac446","volume":"50","author":"MN Nguyen","year":"2022","unstructured":"Nguyen, M. N. et al. AllerCatPro 2.0: A web server for predicting protein allergenicity potential. Nucleic Acids Res. 50, W36\u2013W43. https:\/\/doi.org\/10.1093\/nar\/gkac446 (2022).","journal-title":"Nucleic Acids Res."},{"key":"59872_CR32","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0073957","volume":"8","author":"S Gupta","year":"2013","unstructured":"Gupta, S. et al. In Silico approach for predicting toxicity of peptides and proteins. PLoS ONE 8, e73957. https:\/\/doi.org\/10.1371\/journal.pone.0073957 (2013).","journal-title":"PLoS ONE"},{"key":"59872_CR33","doi-asserted-by":"publisher","DOI":"10.1186\/1471-2105-14-49","author":"BL LaMarche","year":"2013","unstructured":"LaMarche, B. L. et al. MultiAlign: A multiple LC-MS analysis tool for targeted omics analysis. BMC Bioinform. https:\/\/doi.org\/10.1186\/1471-2105-14-49 (2013).","journal-title":"BMC Bioinform."},{"key":"59872_CR34","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1109\/mcse.2007.55","volume":"9","author":"JD Hunter","year":"2007","unstructured":"Hunter, J. D. MatPlotLib: A 2D Graphics environment. Comput. Sci. Eng. 9, 90\u201395. https:\/\/doi.org\/10.1109\/mcse.2007.55 (2007).","journal-title":"Comput. Sci. Eng."},{"key":"59872_CR35","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1093\/bioinformatics\/14.4.378","volume":"14","author":"T Hirokawa","year":"1998","unstructured":"Hirokawa, T., Boon-Chieng, S. & Mitaku, S. SOSUI: Classification and secondary structure prediction system for membrane proteins. Bioinformatics 14, 378\u2013379. https:\/\/doi.org\/10.1093\/bioinformatics\/14.4.378 (1998).","journal-title":"Bioinformatics"},{"key":"59872_CR36","doi-asserted-by":"publisher","DOI":"10.1142\/9789812799623_0029","author":"R Gupta","year":"2001","unstructured":"Gupta, R. & Brunak, S. Prediction of glycosylation across the human proteome and the correlation to protein function. Biocomputing https:\/\/doi.org\/10.1142\/9789812799623_0029 (2001).","journal-title":"Biocomputing"},{"key":"59872_CR37","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-4939-6412-3_14","author":"ST Loughran","year":"2016","unstructured":"Loughran, S. T., Bree, R. T. & Walls, D. Purification of polyhistidine-tagged proteins. Methods Mol. Biol. https:\/\/doi.org\/10.1007\/978-1-4939-6412-3_14 (2016).","journal-title":"Methods Mol. Biol."},{"key":"59872_CR38","doi-asserted-by":"publisher","first-page":"3389","DOI":"10.1093\/nar\/25.17.3389","volume":"25","author":"S Altschul","year":"1997","unstructured":"Altschul, S. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucleic Acids Res. 25, 3389\u20133402. https:\/\/doi.org\/10.1093\/nar\/25.17.3389 (1997).","journal-title":"Nucleic Acids Res."},{"key":"59872_CR39","doi-asserted-by":"publisher","first-page":"3098","DOI":"10.1093\/bioinformatics\/btx345","volume":"33","author":"M Hebditch","year":"2017","unstructured":"Hebditch, M., Carballo-Amador, M. A., Charonis, S., Curtis, R. & Warwicker, J. Protein\u2013Sol: A web tool for predicting protein solubility from sequence. Bioinformatics 33, 3098\u20133100. https:\/\/doi.org\/10.1093\/bioinformatics\/btx345 (2017).","journal-title":"Bioinformatics"},{"key":"59872_CR40","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0009862","volume":"5","author":"N Rapin","year":"2010","unstructured":"Rapin, N., Lund, O., Bernaschi, M. & Castiglione, F. Computational immunology meets bioinformatics: the use of prediction tools for molecular binding in the simulation of the immune system. PLoS ONE 5, e9862. https:\/\/doi.org\/10.1371\/journal.pone.0009862 (2010).","journal-title":"PLoS ONE"},{"key":"59872_CR41","doi-asserted-by":"publisher","first-page":"W526","DOI":"10.1093\/nar\/gki376","volume":"33","author":"A Grote","year":"2005","unstructured":"Grote, A. et al. JCat: A novel tool to adapt codon usage of a target gene to its potential expression host. Nucleic Acids Res. 33, W526\u2013W531. https:\/\/doi.org\/10.1093\/nar\/gki376 (2005).","journal-title":"Nucleic Acids Res."},{"key":"59872_CR42","doi-asserted-by":"publisher","first-page":"161","DOI":"10.2144\/btn-2020-0034","volume":"69","author":"HY Tham","year":"2020","unstructured":"Tham, H. Y., Song, A. A., Yusoff, K. & Tan, G. H. Effect of different cloning strategies in PET-28A on solubility and functionality of a staphylococcal phage endolysin. Biotechniques 69, 161\u2013170. https:\/\/doi.org\/10.2144\/btn-2020-0034 (2020).","journal-title":"Biotechniques"},{"key":"59872_CR43","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1038\/s41586-024-07487-w","volume":"630","author":"J Abramson","year":"2024","unstructured":"Abramson, J. et al. Accurate structure prediction of biomolecular interactions with AlphaFold 3. Nature 630, 493\u2013500. https:\/\/doi.org\/10.1038\/s41586-024-07487-w (2024).","journal-title":"Nature"},{"issue":"2021","key":"59872_CR44","doi-asserted-by":"publisher","first-page":"W530","DOI":"10.1093\/nar\/gkab294","volume":"49","author":"MF Adasme","year":"2021","unstructured":"Adasme, M. F. et al. PLIP 2021: Expanding the scope of the protein\u2013ligand interaction profiler to DNA and RNA. Nucleic Acids Res. 49(2021), W530\u2013W534. https:\/\/doi.org\/10.1093\/nar\/gkab294 (2021).","journal-title":"Nucleic Acids Res."},{"key":"59872_CR45","unstructured":"Assemblies of putative SARS-CoV2-spike-encoding mRNA sequences for vaccines BNT-162b2 and mRNA-1273, Virological (2021). https:\/\/virological.org\/t\/assemblies-of-putative-sars-cov2-spike-encoding-mrna-sequences-for-vaccines-bnt-162b2-and-mrna-1273\/663"},{"key":"59872_CR46","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1038\/mt.2008.200","volume":"16","author":"K Karik\u00f3","year":"2008","unstructured":"Karik\u00f3, K. et al. Incorporation of pseudouridine into mRNA yields superior nonimmunogenic vector with increased translational capacity and biological stability. Mol. Ther. 16, 1833\u20131840. https:\/\/doi.org\/10.1038\/mt.2008.200 (2008).","journal-title":"Mol. Ther."},{"key":"59872_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/1748-7188-6-26","author":"R Lorenz","year":"2011","unstructured":"Lorenz, R. et al. ViennaRNA Package 2.0. Algorithms Mol. Biol. https:\/\/doi.org\/10.1186\/1748-7188-6-26 (2011).","journal-title":"Algorithms Mol. Biol."},{"key":"59872_CR48","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1093\/cid\/ciz1249","volume":"72","author":"J Papenburg","year":"2020","unstructured":"Papenburg, J. & Alghounaim, M. Unraveling the pneumonia burden associated with human metapneumovirus infection. Clin. Infect. Dis. 72, 118\u2013120. https:\/\/doi.org\/10.1093\/cid\/ciz1249 (2020).","journal-title":"Clin. Infect. Dis."},{"key":"59872_CR49","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2023.2293300","author":"S Ma","year":"2024","unstructured":"Ma, S. et al. Development of a novel multi-epitope mRNA vaccine candidate to combat HMPV virus. Hum. Vaccines Immunother. https:\/\/doi.org\/10.1080\/21645515.2023.2293300 (2024).","journal-title":"Hum. Vaccines Immunother."},{"key":"59872_CR50","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1159\/000445059","volume":"58","author":"X Li","year":"2015","unstructured":"Li, X. et al. Design and evaluation of a multi-epitope peptide of human metapneumovirus. Intervirology 58, 403\u2013412. https:\/\/doi.org\/10.1159\/000445059 (2015).","journal-title":"Intervirology"},{"key":"59872_CR51","doi-asserted-by":"publisher","DOI":"10.1016\/j.humimm.2025.111557","volume":"86","author":"F Ullah","year":"2025","unstructured":"Ullah, F. et al. An in-silico design of a multi-epitope vaccine candidate against human metapneumovirus (HMPV) through prediction of B- and T-cell epitopes and molecular dynamics simulation. Hum. Immunol. 86, 111557. https:\/\/doi.org\/10.1016\/j.humimm.2025.111557 (2025).","journal-title":"Hum. Immunol."},{"key":"59872_CR52","doi-asserted-by":"publisher","first-page":"964","DOI":"10.1186\/s12879-025-11339-x","volume":"25","author":"M Ehsasatvatan","year":"2025","unstructured":"Ehsasatvatan, M., Kohnehrouz, B. B. & Salavatizadeh, M. Immunoinformatic design of chimeric multiepitope vaccine for the prevention of human metapneumovirus (hMPV). BMC Infect. Dis. 25, 964. https:\/\/doi.org\/10.1186\/s12879-025-11339-x (2025).","journal-title":"BMC Infect. Dis."},{"key":"59872_CR53","doi-asserted-by":"publisher","first-page":"45014","DOI":"10.1038\/s41598-025-28522-4","volume":"15","author":"K Bukhari","year":"2025","unstructured":"Bukhari, K. Multi-epitope vaccine design against human metapneumovirus via reverse vaccinology and molecular modelling. Sci. Rep. 15, 45014. https:\/\/doi.org\/10.1038\/s41598-025-28522-4 (2025).","journal-title":"Sci. Rep."},{"key":"59872_CR54","doi-asserted-by":"publisher","first-page":"394","DOI":"10.1007\/s13337-025-00932-y","volume":"36","author":"DF Rao","year":"2025","unstructured":"Rao, D. F., Patel, S. K. & Pandya, H. A. Development of a multi-epitope vaccine candidate targeting conserved regions of human metapneumovirus. VirusDisease 36, 394\u2013414. https:\/\/doi.org\/10.1007\/s13337-025-00932-y (2025).","journal-title":"VirusDisease"},{"key":"59872_CR55","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1038\/s41598-025-29906-2","volume":"16","author":"MA Izhari","year":"2025","unstructured":"Izhari, M. A. et al. Rational design and in silico characterization of a multiepitope mRNA vaccine candidate against human metapneumovirus (hMPV) using reverse vaccinology and immunoinformatics approaches. Sci. Rep. 16, 540. https:\/\/doi.org\/10.1038\/s41598-025-29906-2 (2025).","journal-title":"Sci. Rep."},{"key":"59872_CR56","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1007\/s10822-025-00732-y","volume":"40","author":"AK Singhmar","year":"2025","unstructured":"Singhmar, A. K., Goyal, V., Kumari, S. & Grewal, S. Designing a multi-epitope mRNA vaccine to combat human metapneumovirus based on consensus sequence using reverse vaccinology. J. Comput. Aided Mol. Des. 40, 20. https:\/\/doi.org\/10.1007\/s10822-025-00732-y (2025).","journal-title":"J. Comput. Aided Mol. Des."},{"key":"59872_CR57","doi-asserted-by":"publisher","DOI":"10.1016\/j.compbiomed.2025.110935","volume":"196","author":"MSM Supto","year":"2025","unstructured":"Supto, M. S. M. et al. Next-generation multi-epitope subunit vaccine design: A computational approach utilizing two stable proteins to combat Human Metapneumovirus (HMPV). Comput. Biol. Med. 196, 110935. https:\/\/doi.org\/10.1016\/j.compbiomed.2025.110935 (2025).","journal-title":"Comput. Biol. Med."},{"key":"59872_CR58","doi-asserted-by":"publisher","DOI":"10.1080\/21645515.2024.2311974","author":"H Daungsupawong","year":"2024","unstructured":"Daungsupawong, H. & Wiwanitkit, V. Multi-epitope mRNA vaccine candidate to combat HMPV virus: Comment. Hum. Vaccines Immunother. https:\/\/doi.org\/10.1080\/21645515.2024.2311974 (2024).","journal-title":"Hum. Vaccines Immunother."},{"key":"59872_CR59","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1097\/qco.0000000000000948","volume":"36","author":"JA Whitaker","year":"2023","unstructured":"Whitaker, J. A., Sahly, H. M. E. & Healy, C. M. mRNA vaccines against respiratory viruses. Curr. Opin. Infect. Dis. 36, 385\u2013393. https:\/\/doi.org\/10.1097\/qco.0000000000000948 (2023).","journal-title":"Curr. Opin. Infect. Dis."},{"key":"59872_CR60","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1038\/s41573-021-00283-5","volume":"20","author":"N Chaudhary","year":"2021","unstructured":"Chaudhary, N., Weissman, D. & Whitehead, K. A. mRNA vaccines for infectious diseases: Principles, delivery and clinical translation. Nat. Rev. Drug Discovery 20, 817\u2013838. https:\/\/doi.org\/10.1038\/s41573-021-00283-5 (2021).","journal-title":"Nat. Rev. Drug Discovery"},{"key":"59872_CR61","doi-asserted-by":"publisher","first-page":"65","DOI":"10.3390\/vaccines9010065","volume":"9","author":"MD Buschmann","year":"2021","unstructured":"Buschmann, M. D. et al. Nanomaterial delivery systems for mRNA vaccines. Vaccines 9, 65. https:\/\/doi.org\/10.3390\/vaccines9010065 (2021).","journal-title":"Vaccines"},{"key":"59872_CR62","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.1081047","author":"T Nogimori","year":"2023","unstructured":"Nogimori, T. et al. Functional changes in cytotoxic CD8+ T-cell cross-reactivity against the SARS-CoV-2 Omicron variant after mRNA vaccination. Front. Immunol. https:\/\/doi.org\/10.3389\/fimmu.2022.1081047 (2023).","journal-title":"Front. Immunol."},{"key":"59872_CR63","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1134\/s0026893321030080","volume":"55","author":"KA Lashkevich","year":"2021","unstructured":"Lashkevich, K. A. & Dmitriev, S. E. MRNA targeting, transport and local translation in eukaryotic cells: From the classical view to a diversity of new concepts. Mol. Biol. 55, 507\u2013537. https:\/\/doi.org\/10.1134\/s0026893321030080 (2021).","journal-title":"Mol. Biol."},{"key":"59872_CR64","doi-asserted-by":"publisher","first-page":"747","DOI":"10.3390\/vaccines11040747","volume":"11","author":"G Giannotta","year":"2023","unstructured":"Giannotta, G., Murrone, A. & Giannotta, N. COVID-19 mRNA vaccines: The molecular basis of some adverse events. Vaccines 11, 747. https:\/\/doi.org\/10.3390\/vaccines11040747 (2023).","journal-title":"Vaccines"},{"key":"59872_CR65","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-023-01579-1","author":"G Zhang","year":"2023","unstructured":"Zhang, G., Tang, T., Chen, Y., Huang, X. & Liang, T. mRNA vaccines in disease prevention and treatment. Signal Transduct. Target. Therapy https:\/\/doi.org\/10.1038\/s41392-023-01579-1 (2023).","journal-title":"Signal Transduct. Target. Therapy"},{"key":"59872_CR66","doi-asserted-by":"publisher","unstructured":"Kremsner, G. et al. HERALD Study Group. Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate: results from Herald, a Phase 2b\/3, Randomised, Observer-Blinded, Placebo-Controlled Clinical Trial in Ten Countries in Europe and Latin America, SSRN Electronic Journal. https:\/\/doi.org\/10.2139\/ssrn.3911826 (2021)","DOI":"10.2139\/ssrn.3911826"},{"key":"59872_CR67","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1021\/acscentsci.1c00197","volume":"7","author":"KD Nance","year":"2021","unstructured":"Nance, K. D. & Meier, J. L. Modifications in an emergency: The role of N1-Methylpseudouridine in COVID-19 vaccines. ACS Cent. Sci. 7, 748\u2013756. https:\/\/doi.org\/10.1021\/acscentsci.1c00197 (2021).","journal-title":"ACS Cent. Sci."},{"key":"59872_CR68","doi-asserted-by":"publisher","first-page":"245","DOI":"10.1007\/s12272-022-01381-7","volume":"45","author":"S Kwon","year":"2022","unstructured":"Kwon, S., Kwon, M., Im, S., Lee, K. & Lee, H. mRNA vaccines: The most recent clinical applications of synthetic mRNA. Arch. Pharmacal Res. 45, 245\u2013262. https:\/\/doi.org\/10.1007\/s12272-022-01381-7 (2022).","journal-title":"Arch. Pharmacal Res."},{"key":"59872_CR69","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2021.789427","author":"P Morais","year":"2021","unstructured":"Morais, P., Adachi, H. & Yu, Y.-T. The critical contribution of pseudouridine to mRNA COVID-19 vaccines. Front. Cell Dev. Biol. https:\/\/doi.org\/10.3389\/fcell.2021.789427 (2021).","journal-title":"Front. Cell Dev. Biol."},{"key":"59872_CR70","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pbio.0040180","volume":"4","author":"G Kudla","year":"2006","unstructured":"Kudla, G., Lipinski, L., Caffin, F., Helwak, A. & Zylicz, M. High guanine and cytosine content increases mRNA levels in mammalian cells. PLoS Biol. 4, e180. https:\/\/doi.org\/10.1371\/journal.pbio.0040180 (2006).","journal-title":"PLoS Biol."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59872-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59872-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59872-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T22:47:29Z","timestamp":1790030849000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-59872-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6,25]]},"references-count":70,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["59872"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-59872-2","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,6,25]]},"assertion":[{"value":"22 September 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"23 June 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 June 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"29380"}}